Publication | Closed Access

Development and validation of a bioanalytical method based on LC–MS/MS analysis for the quantitation of CIGB-814 peptide in plasma from Rheumatoid Arthritis patients

Rheumatoid DisorderRheumatologyBioanalytical MethodAutoimmune DiseaseBioanalysisImmunologyMass SpectrometryPathologyCigb-814 PeptideInflammatory Rheumatic DiseaseBiomedical AnalysisRheumatoid Arthritis PatientsClinical ChemistryMedicineRheumatoid Arthritis